Merck, Daiichi Sankyo scrap FDA application for HER3 ADC after survival missnews2025-05-29T12:14:21+00:00May 29th, 2025|Endpoints News|
Trump axes Moderna bird flu pact worth more than $750Mnews2025-05-28T22:01:41+00:00May 28th, 2025|Endpoints News|
Novo Nordisk ‘strongly’ urges US away from pharma tariffsnews2025-05-28T17:46:09+00:00May 28th, 2025|Endpoints News|
A new dawn for psychedelics? Compass could be the first to find outnews2025-05-28T14:00:03+00:00May 28th, 2025|Endpoints News|
Axsome and Hetero settle patent fight over sleep disorder drugnews2025-05-27T18:50:07+00:00May 27th, 2025|Endpoints News|
FDA rejects Savara’s rare lung disease drug over limited manufacturing datanews2025-05-27T17:04:35+00:00May 27th, 2025|Endpoints News|
Lilly to buy non-opioid pain biotech SiteOne for up to $1Bnews2025-05-27T15:02:17+00:00May 27th, 2025|Endpoints News|
FDA approves Liquidia’s inhaled hypertension drug in two settingsnews2025-05-27T14:47:14+00:00May 27th, 2025|Endpoints News|
Biogen taps City Therapeutics in RNAi deal worth up to $1Bnews2025-05-27T13:19:48+00:00May 27th, 2025|Endpoints News|
Blackstone’s GRIN inks epilepsy licensing deal with Angelini, closes $140M Series Dnews2025-05-27T12:30:28+00:00May 27th, 2025|Endpoints News|
